ESMO Colloquium supported by Lilly Oncology in collaboration with MSD - How to best use immune checkpoint inhibitors in NSCLC: Single agents or combined with chemotherapy? ESMO Colloquium

Recommendation on second-line treatment according to first-line choice

Lecture Time
12:50 - 13:10
Speakers
  • D. Planchard (Villejuif, France)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
11:45 - 13:15
Authors
  • D. Planchard (Villejuif, France)